Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to Candida albicans

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Clinical Microbiology

• Publication date

  1987-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jcm.25.2.230-237.1987PMID 3546361PMCID PMC265873
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera

  1986cited by this paper
• A reverse passive latex agglutination test for the diagnosis of systemic candidosis.

  1985cited by this paper
• Use of immunoblotting to identify antigenic differences between the yeast and mycelial phases of Candida albicans.

  1985cited by this paper
• Outbreak of systemic Candida albicans in intensive care unit caused by cross infection.

  1985cited by this paper
• Serologic analysis of antigen-specific reactivity in patients with systemic candidiasis.

  1985influential reference
• Diagnosis of systemic candidiasis by latex agglutination for serum antigen

  1985cited by this paper
• Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis

  1985cited by this paper
• Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera

  1984cited by this paper
• Production and characterization of three monoclonal antibodies to Candida albicans proteins

  1984cited by this paper
• Immunoblot analysis of the serological response in systemic candidosis.

  1984cited by this paper
• Immunoblotting and dot immunobinding--current status and outlook.

  1984cited by this paper
• Circulating immune complexes in patients with Candida albicans infections.

  1983cited by this paper
• Latex agglutination test for detection of Candida antigen in patients with disseminated disease

  1983cited by this paper
• Diagnostic value of the enzyme-linked immunosorbent assay for detection of Candida albicans cytoplasmic antigen in sera of cancer patients

  1982cited by this paper
• Purification and characterization of a major cytoplasmic antigen of Candida albicans

  1981cited by this paper
• Quantitation of antibody against cell wall mannan and a major cytoplasmic antigen of Candida in rabbits, mice, and humans

  1980cited by this paper
• Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique

  1979cited by this paper

• The therapeutic potential of phage-based antifungal treatment: strategies, mechanisms, and prospects.

  2025cites this paper
• Monoclonal antibodies: From magic bullet to precision weapon

  2024cites this paper
• Promising immunotherapeutic targets for treating candidiasis

  2024cites this paper
• Vaccines against candidiasis: Status, challenges and emerging opportunity

  2022cites this paper
• The prophylactic effects of monoclonal antibodies targeting the cell wall Pmt4 protein epitopes of Candida albicans in a murine model of invasive candidiasis

  2022cites this paper
• Potential of Polyethyleneimine as an Adjuvant To Prepare Long-Term and Potent Antifungal Nanovaccine

  2022cites this paper
• Harnessing the Immune Response to Fungal Pathogens for Vaccine Development.

  2022cites this paper
• DNA barcoding analysis of more than 1000 marine yeast isolates reveals previously unrecorded species

  2020cites this paper
• Monoclonal Antibodies as Tools to Combat Fungal Infections

  2020cites this paper
• Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections

  2020cites this paper
• Candida parapsilosis: from Genes to the Bedside

  2019cites this paper
• Study of the effect of candida albicans recombinant proteins and derived monoclonal antibodies on protumoral processes and as diagnostic and therapeutic tools

  2018influential citation
• The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future

  2018cites this paper
• Candida albicans Heat Shock Proteins and Hsps-Associated Signaling Pathways as Potential Antifungal Targets

  2017influential citation
• Serum Antibody Profile during Colonization of the Mouse Gut by Candida albicans: Relevance for Protection during Systemic Infection.

  2017cites this paper
• Vaccination with Phage-Displayed Antigenic Epitope.

  2017cites this paper
• Differential Gene Expression of Heat Shock Protein 90 (Hsp90) of Candida albicans obtained from Malaysian and Iranian Patients.

  2016cites this paper
• Identification and characterization of transcription factors involved in morphogenesis in the human fungal pathogen Candida albicans

  2016cites this paper
• The protective role of immunoglobulins in fungal infections and inflammation

  2015cites this paper
• Candida in health and disease-A review

  2015cites this paper
• Heat Shock Protein 90 (Hsp90) in Fungal Growth and Pathogenesis

  2014cites this paper
• Serum antibody signature directed against Candida albicans Hsp90 and enolase detects invasive candidiasis in non-neutropenic patients.

  2014cites this paper
• Heat shock protein 90 (Hsp90): A novel antifungal target against Aspergillus fumigatus

  2014cites this paper
• Adjuvant effect of polysaccharide from fruits of Physalis alkekengi L. in DNA vaccine against systemic candidiasis.

  2014cites this paper
• Human Monoclonal Antibody-Based Therapy in the Treatment of Invasive Candidiasis

  2013cites this paper
• Stress Responses in Candida

  2012cites this paper
• Vaccines and Passive Immunity against Candidiasis

  2012cites this paper
• Les thérapeutiques anti-infectieuses non antibiotiques Antiinfective therapies other than antibiotics

  2012cites this paper
• Les thérapeutiques anti-infectieuses non antibiotiques

  2012cites this paper
• Dose Range Evaluation of Mycograb C28Y Variant, a Human Recombinant Antibody Fragment to Heat Shock Protein 90, in Combination with Amphotericin B-Desoxycholate for Treatment of Murine Systemic Candidiasis

  2011cites this paper
• The relevance of heat shock regulation in fungal pathogens of humans

  2010cites this paper
• Candida y candidiasis invasora: un reto continuo para su diagnóstico temprano

  2010cites this paper
• Potential of anti-Candida antibodies in immunoprophylaxis.

  2010cites this paper
• Cell Wall/Surface Proteome of Candida albicans: its Application in Rapid Identification of Yeast Species by Mass Signature and Characterization by in vitro and in vivo Chemical Labelings

  2010cites this paper
• Immunoproteomic approach to elucidating the pathogenesis of cryptococcosis caused by Cryptococcus gattii.

  2010cites this paper
• Mycoserology and Molecular Diagnosis

  2010cites this paper
• The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans.

  2010cites this paper
• Role of the heat shock transcription factor, Hsf1, in a major fungal pathogen that is obligately associated with warm-blooded animals

  2009cites this paper
• The role of adjuvant agents in treating fungal diseases

  2009cites this paper
• Role of the heat shock transcription factor , Hsf 1 , in a major fungal pathogen that is obligately associated with warm-blooded animalsmmi

  2009cites this paper
• De nouvelles molécules pour les infections fongiques

  2009cites this paper
• Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases

  2008cites this paper
• Efungumab and caspofungin: pre-clinical data supporting synergy.

  2008cites this paper
• Immunocompromised hosts: immunopharmacology of modern antifungals.

  2008cites this paper
• Heat shock proteins in immune reactions

  2008cites this paper
• An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In Vivo

  2007cites this paper
• Serodiagnosis: Antibody and Antigen Detection

  2007cites this paper
• Preparation of combined extract of cell wall and cytosol antigens of Candida albicans for immunoblot analysis

  2007cites this paper
• Immunomodulatory therapy in yeast infections

  2007cites this paper
• A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis.

  2006cites this paper
• HSP90: The Unsung Villain of Sepsis?

  2006cites this paper
• Acquired Antibody-Mediated Immunity to Fungi

  2006cites this paper
• Serological and Molecular Diagnosis of Fungal Infections

  2006cites this paper
• Fungal heat-shock proteins in human disease.

  2006cites this paper
• El diagnóstico microbiológico independiente del cultivo en la candidiasis invasora. Importancia de los marcadores fúngicos

  2006cites this paper
• The third age of antimicrobial therapy.

  2006cites this paper
• Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice.

  2006cites this paper
• [Microbiological non-culture methods for the diagnosis of invasive candidiasis: usefulness of surrogate markers].

  2006cites this paper
• Epitope mapping Candida albicans proteinase (SAP 2).

  2006cites this paper
• Human recombinant antibody to HSP90: a natural partner in combination therapy.

  2005cites this paper
• Humoral Factors in the Protection of the Oral Cavity against Candidiasis

  2005cites this paper
• Fungal heat-shockproteins in humandisease

  2005cites this paper
• Active and passive immunization against oral Candida albicans infection in a murine model.

  2005cites this paper
• Laboratory diagnosis of invasive candidiasis.

  2005cites this paper
• Prophylactic vaccination with phage-displayed epitope of C. albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice.

  2005cites this paper
• Developments in the serologjcal diagnosis of opportunistic fnngal infections

  2005cites this paper
• Recombinant antibodies: a natural partner in combinatorial antifungal therapy.

  2004cites this paper
• Genetically recombinant antibodies: new therapeutics against candidiasis

  2004cites this paper
• Heat Shock Response in Pathogenic Fungi

  2004cites this paper
• Proteomics‐based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies

  2004cites this paper
• Occasional articles Diagnosing fungal infections in immunocompromised hosts

  2004cites this paper
• Advances in Diagnostic Methods for Invasive Candida and Aspergillus Infections

  2004cites this paper
• Isolation and identification of a 92-kDa stress induced protein from Candida albicans

  2004cites this paper
• Preclinical Assessment of the Efficacy of Mycograb, a Human Recombinant Antibody against Fungal HSP90

  2003cites this paper
• The role of antibodies against hsp90 in the treatment of fungal infections.

  2003cites this paper
• Isolation and partial characterization of Hsp90 from Candida albicans.

  2003cites this paper
• Isolation and Partial Characterization of Hsp 90 from Candida albicans

  2003cites this paper
• Induced humoral immunity and vaccination against major human fungal pathogens.

  2002cites this paper
• Fungal Infection in the Intensive Care Unit

  2002cites this paper
• Laboratory Diagnosis of Fungal Infection in the Intensive Care Unit

  2002cites this paper
• [Advances in serological systems for diagnosis of systemic fungal infections, particularly those caused by Candida and Aspergillus].

  2002cites this paper
• Identification of Major Glucan-Associated Cell Wall Proteins of Candida albicans and Their Role in Fluconazole Resistance

  2002cites this paper
• Salivary IgA and serum IgA and IgG antibodies to Candida albicans in HIV-infected subjects

  2002cites this paper
• Immunodominant antigens in periodontal disease: a real or illusive concept?

  2001cites this paper
• Adjunctive immune therapy for fungal infections.

  2001cites this paper
• Immunoreactivity of the fungal cell wall.

  2001cites this paper
• Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

  2000cites this paper
• Systemic Infections with Candida sp. and Aspergillus sp. in Immunocompromised Patients with Hematological Malignancies: Current Serological and Molecular Diagnostic Methods

  2000cites this paper
• Current serological and molecular methods in the diagnosis of systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies.

  2000cites this paper
• The Hsp90 of Candida albicans can confer Hsp90 functions in Saccharomyces cerevisiae: a potential model for the processes that generate immunogenic fragments of this molecular chaperone in C. albicans infections.

  1999influential citation
• Cellular localization of a Hsp90 homologue in Porphyromonas gingivalis.

  1999cites this paper
• Characterization of Candida albicans antigenic determinants by two-dimensional polyacrylamide gel electrophoresis and enhanced chemiluminescence.

  1999cites this paper
• Cell wall proteinaceous components in isolates of Candida albicans and non-albicans species from HIV-infected patients with oropharyngeal candidiasis.

  1998cites this paper
• Candida albicans fibrinogen binding mannoprotein: expression in clinical strains and immunogenicity in patients with candidiasis.

  1998cites this paper
• Immune responses to stress proteins: Applications to infectious disease and cancer

  1998cites this paper
• The role of antibodies in protection against candidiasis.

  1998cites this paper
• Stress proteins in fungal diseases.

  1998cites this paper
• Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression

  1998cites this paper
• Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated Candidiasis

  1997cites this paper
• Defining antibody targets in Streptococcus oralis infection

  1996cites this paper